TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Toosendanin, Camptothecin
Phytochemical Name Toosendanin (PubChem CID: 9851101 )
Anticancer drug Name Camptothecin (PubChem CID: 24360 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 220
Pair Name Toosendanin, Camptothecin
Disease Info [ICD-11: 2C77] Cervical cancer Investigative
Biological Phenomena Induction-->Autophagy
Gene Regulation Down-regulation Activity ATP6AP2 hsa10159
Down-regulation Expression CTSB hsa1508
Down-regulation Expression CTSD hsa1509
Up-regulation Expression SQSTM1 hsa8878
In Vitro Model HeLa Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_0030
A-549 Lung adenocarcinoma Homo sapiens (Human) CVCL_0023
In Vivo Model 1×10⁶ HeLa cells stably expressing mRFP-GFP-LC3 were suspended in 100 μL serum-free culture medium and inoculated into the left axilla.
Result These results suggest that toosendanin has the potential to be developed into an anti-cancer drug by blocking chemotherapy-induced protective autophagy.
03. Reference
No. Title Href
1 Toosendanin, a novel potent vacuolar-type H+-translocating ATPase inhibitor, sensitizes cancer cells to chemotherapy by blocking protective autophagy. Int J Biol Sci. 2022 Mar 28;18(7):2684-2702. doi: 10.7150/ijbs.71041. Click
It has been 47973 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP